Lilly Announces $850 Million Investment in U.S. Capital Projects in 2017
Significant investment in manufacturing diabetes medicines continues with new $85 million commitment in Indianapolis $5 billion invested in its U.S. operations over the last decade; more favorable tax climate could lead to additional U.S. investments INDIANAPOLIS, March 24, 2017 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) today announced plans to invest $850 million in its […]